Research article · 12 Jun 2025
Conference abstractPublished 2016
Potential therapeutic application of dendrimer/cyclodextrin conjugates with targeting ligands as advanced carriers for gene and oligonucleotides drugs
Kumamoto University, Japan
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
So far, we have reported that gene, shRNA and siRNA transfer activity of PAMAM dendrimers (G2-G4) was strikingly increased by conjugation with α-cyclodextrin (α-CyD) through both an increase in the endosomal escaping effect and a decreasing in cytotoxicity of the dendrimers. However, the PAMAM dendrimer conjugates with α-CyD (α-CDEs) have no cell-selective gene and oligonucleotides transfer activity. Therefore, we have recently prepared various α-CDEs having targeting ligands such as folate, lactose and mannose/fucose as non-viral vectors to deliver DNA, shRNA, siRNA, miRNA and decoy DNA to tumor cells, hepatocytes and Kupffer cells, respectively, since they possess cell-selective entry, endosomal escaping ability, serum resistance and high safe profile. Most recently, we demonstrated that 2PAMAM dendrimer (G3) conjugates with glucuronylglucosyl-β-cyclodextrin (GUG-β-CDE (G3)) provided superior properties to α-CDE (G3). Also, we fairly recently found that sacran, a megamolecular polysaccharide derived from Aphanothece sacrum, enhanced cellular uptake and the RNAi effect of siRNA complexes with α-CDEs via a formation of ternary complexes. I will introduce the recent progress of α-CDEs and GUG-β-CDEs as cell-selective non-viral vectors.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pharmaceutics & Drug Delivery Research.
Research article · 20 Feb 2025
Sustained Drug Delivery in Pharmaceutical Dosage Forms for Novel Approaches of Formulation Design
Research article · 23 Jan 2025
Cutting Out Counterfeits: How Blockchain Can Revolutionize Drug Traceability?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pharmaceutics & Drug Delivery Research
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Hidetoshi Arima”
- BylineArticles whose byline prints “Keiichi Motoyama”
- BylineArticles whose byline prints “Taishi Higashi”
